Measured Wealth Private Client Group, LLC
Position in SCLX — Scilex Holding Co
CIK 1720235
PORTSMOUTH, NH
Position in SCLX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$26
-$22 QoQ
Shares Held
4
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Measured Wealth Private Client Group, LLC holds $3,974,731 across 13 Drug Manufacturers - General names. SCLX ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
25,075 | $1,520,798 | |
| 2 | JNJ |
Johnson & Johnson
|
3,336 | $815,451 | |
| 3 | ABBV |
AbbVie Inc.
|
2,142 | $465,863 | |
| 4 | AMGN |
Amgen Inc
|
905 | $318,424 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,518 | $302,890 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,072 | $288,774 | |
| 7 | LLY |
ELI LILLY & Co
|
114 | $104,853 | |
| 8 | PFE |
Pfizer Inc
|
2,283 | $64,106 |
All Filings in SCLX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26 | 4 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $48 | 4 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $78 | 4 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||